The U.S. FDA Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has recommended approval of Sanofi’s New Drug Application…
The Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted 16-0, recommending the…
Today the U.S. Food and Drug Administration (FDA) announced a new Nutrition Facts label for most packaged foods that reflects the latest in nutrition…
The FDA issued a safety communication alerting the public about interim safety results from an ongoing clinical trial that found an increase…
Ascensia Diabetes Care has received CE Mark for the new CONTOUR NEXT ONE and CONTOUR PLUS ONE blood glucose monitoring systems, which will allow…
Medtronic Inc. has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise study,…
LifeScan has introduced the new OneTouch Verio Flex blood glucose monitoring system, with ColorSure technology – a simple, accurate and easy-to-use…
Abbott Diabetes Care announced that it has obtained CE Mark for the FreeStyle Libre flash glucose monitoring system indicated for children and teens with diabetes aged 4-17 years old.
The U.S. FDA has approved Animas Vibe Insulin Pump and Continuous Glucose Monitoring (CGM) System for management of diabetes in children and adolescents,…
The U.S. FDA approved Basaglar (insulin glargine injection), the newest diabetes treatment from the Lilly-Boehringer Ingelheim diabetes…